HeadaTerm 2: An Affordable FDA-Cleared Alternative to Cefaly for Migraine Relief
Posted on April 29 2024,
If you have migraine disease, you may have heard of Cefaly - the popular FDA-approved device that uses external trigeminal nerve stimulation (eTNS) technology to prevent and treat migraine headaches. While effective, Cefaly comes with a hefty price tag of around $350. But there's good news for patients with migraine on a budget. A newer device called HeadaTerm 2 utilizes the same eTNS technology as Cefaly at a much more affordable price point of just $99.99. In fact, HeadaTerm 2 is currently offering a pre-sale discount of up to 30% off, bringing the cost down to $70.
How does HeadaTerm 2 work?
Like Cefaly, HeadaTerm 2 is worn on the forehead and delivers targeted electrical impulses to stimulate the trigeminal nerve, which has been shown to increase pain tolerance and prevent migraine attacks. In clinical trials, eTNS was found to be up to 27% more effective than oral migraine medications - without the unwanted side effects.
Acute Treatment: Use medium to high intensity for continuous treatment of one hour. If the migraine attack is not fully relieved, add an additional hour.
Preventive Treatment: Use low to medium intensity for continuous treatment of one hour daily. First-time users of e-TNS technology products may experience mild discomfort due to electrical stimulation. It is recommended to start at a low intensity for the first 1-2 sessions (adaptive treatment).
Key features of HeadaTerm 2
- FDA clearance for safety and effectiveness in migraine prevention
- No need for a prescription
- Rechargeable for repeated use
- Simple one-button control to adjust stimulation intensity
- Compact, portable design for on-the-go treatment
- 100% drug-free
- Quick migraine relief
- Affordably priced under $100
HeadaTerm 2 offers a very compelling alternative for those looking for a more budget-friendly option. With its clinically proven effectiveness, ease of use, and reasonable cost, HeadaTerm 2 is well worth considering if you're seeking a non-invasive, drug-free way to prevent and relieve migraine headaches.
When the pre-sale is gone, you can use our code CEREBRALTORQUE for a 20% discount.
Get HeadaTerm 2 NowWed, May 07, 25
Subclinical Hypothyroidism and Migraine: Treatment Shows Decrease in Migraine Frequency and Severity
Discover how treating subclinical hypothyroidism with low-dose levothyroxine may reduce migraine frequency by 28%. Learn about TSH levels, treatment guidelines, and when intervention is recommended.
Read MoreTue, May 06, 25
One Treatment, Two Conditions: Study Reveals Ajovy's Impact on Migraine and Depression
Fremanezumab (Ajovy) for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder Findings from the UNITE randomized clinical trial involving 353 patients with both migraine and depression Based...
Read MoreFri, May 02, 25
Blood Flow Changes Between Migraine Attacks
New research reveals increased cerebral blood flow in migraine patients between attacks. This 4D flow MRI study shows significant hemodynamic changes in the middle and posterior cerebral arteries, with blood...
Read More